About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Hope for Patients Suffering from Primary Biliary Cirrhosis from First Study in a Decade

by Kathy Jones on April 3, 2011 at 8:51 PM
Font : A-A+

 Hope for Patients Suffering from Primary Biliary Cirrhosis from First Study in a Decade

Obeticholic Acid (OCA) is a safe and effective treatment in patients suffering from Primary Biliary Cirrhosis (PBC) as demonstrated by substantial decreases in the levels of alkaline phosphatase (AP) enzyme in the blood, a key marker for PBC, results from an international study presented today at the International Liver Congress have shown.

In this double blind parallel group study, 59 patients received 10 or 50mg of OCA or a placebo once a day for 12 weeks. After 12 weeks the 10mg group showed the greatest reduction in AP levels.

Advertisement

PBC is a chronic disease that slowly destroys some of the tubes (bile ducts) linking the liver to the gut. PBC predominantly affects females at a ratio of approximately nine women to every one man. Bile ducts carry bile to the gut but in patients with PBC, bile can no longer flow through effectively and instead builds up in the liver, damaging the liver cells and causing inflammation and scarring. Long-term damage over the years can result in cirrhosis and liver failure.

Daniele Prati, EAS's Scientific Committee Member and Press Committee Chairman commented: "It is extremely encouraging to see that OCA seems to be effective in patients from a variety of countries. This is the first treatment trial in many years for patients with PBC that has shown such promising results. Further studies are needed to evaluate the action of this therapy compared to existing therapies and in larger patient populations."

OCA, 6-ethyl chenodeoxycholic acid (CDCA) or INT-747, is a novel derivative of CDCA, the natural ligand for the farnesoid-X receptor, a bile acid receptor which is found in the liver.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Alcoholic Liver Disease Bubbles and Brews - Alcohol Facts Liver Autoimmune Disorders Biliary Cirrhosis Fatty Liver Disease: A Growing Health Problem in India Fibroscan for Fatty Liver Cirrhosis and Fibrosis Hepatorenal Syndrome Liver Failure Biliary Atresia 

Most Popular on Medindia

Blood - Sugar Chart The Essence of Yoga Pregnancy Confirmation Calculator Drug Side Effects Calculator Selfie Addiction Calculator Drug - Food Interactions How to Reduce School Bag Weight - Simple Tips Accident and Trauma Care Color Blindness Calculator Diaphragmatic Hernia
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Hope for Patients Suffering from Primary Biliary Cirrhosis from First Study in a Decade Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests